NEW YORK, Jan. 21, 2016 /PRNewswire/ -- Transdermal and Transmucosal Drug Delivery Markets analyzes the current and potential markets for transdermal/transmucosal drug delivery, a well-established accepted route of administration for therapeutically beneficial medicines.
Transdermal and Transmucosal Drug Delivery Markets provides the following market information:The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals, 2013-2020 The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Systems by Type, 2013-2020 The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies, Market Share by Type, 2013-2020 Transdermal/Transmucosal Drug Delivery by Indication by Percent, 2015 (Smoking Cessation, Pain Management, Hormone, Cardio, Others) The Transdermal/Transmucosal Drug Delivery Market by Region, 2013-2020 (United States, Europe, Japan, Rest of World, Global Market) The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2013-2020 Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology The transdermal/transmucosal drug delivery market consists of many companies including large and small pharmaceutical companies as well as large and small drug delivery companies. The competition among participants is intensifying not only within the specific category such as transdermal drug delivery but also among the competing drug delivery technologies to provide the best possible vehicle for administration of a particular pharmaceutical product.
The report profiles companies involved in the transdermal/transmucosal drug delivery market. Drug delivery companies have made tremendous strides in the transdermal/transmucosal drug delivery market. Several companies have products that are already enjoying market success while many others are at various stages of development. There is little doubt that this area of drug delivery will continue to flourish in the coming years.
Challenges remain for the development of transdermal/transmucosal drug delivery systems but continued research will likely break down the barriers that limit the types of drug molecules that may be delivered through the skin. The market is expected to be driven by various factors including the loss of patent protection for blockbuster drugs and the need to avoid the first pass effects of oral drug delivery. Additionally, with an added focus on active transdermal technologies, new applications will likely cause a resurgence of interest in transdermal delivery of products.
Read the full report:
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001